Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	json	split
Results from in vivo expression studies performed with these NF - kappa B p65 mutants revealed the following: 1) I kappa B / MAD - 3 completely inhibits NF - kappa B p65 - dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B / MAD - 3 to NF - kappa B p65 is sufficient to retarget NF - kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF - kappa B p65 disrupts its ability to engage I kappa B / MAD - 3, and 4) the unique C - terminus of NF - kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B - mediated inhibition of NF - kappa B p65 DNA binding activity.	p65,74,77,Protein	MAD - 3,125,132,Protein	p65,166,169,Protein	MAD - 3,337,344,Protein	p65,361,364,Protein	p65,404,407,Protein	p65,562,565,Protein	MAD - 3,609,616,Protein	p65,665,668,Protein	p65,802,805,Protein	"[{""token"": ""p65"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""MAD - 3"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""MAD - 3"", ""start_span"": 337, ""end_span"": 344, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 361, ""end_span"": 364, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 404, ""end_span"": 407, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 562, ""end_span"": 565, ""type"": ""Protein""}, {""token"": ""MAD - 3"", ""start_span"": 609, ""end_span"": 616, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 665, ""end_span"": 668, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 802, ""end_span"": 805, ""type"": ""Protein""}]"	train
Interestingly, apoptosis induced by NF - kappa B suppression, in contrast to that induced by TPEN ( N, N, N ', N ' - tetrakis [ 2 - pyridylmethyl] ethylenediamine) or soluble Fas ligand ( CD95), was observed in the absence of active death effector proteases caspase - 1 - like ( IL - 1 converting enzyme), caspase - 3 - like ( CPP32 / Yama / apopain), and caspase - 6 - like and without cleavage of caspase - 3 substrates poly ( ADP - ribose) polymerase and DNA fragmentation factor - 45.	Fas ligand,175,185,Protein	CD95,188,192,Protein	caspase - 1,258,269,Protein	caspase - 3,306,317,Protein	CPP32,327,332,Protein	Yama,335,339,Protein	apopain,342,349,Protein	caspase - 6,356,367,Protein	caspase - 3,399,410,Protein	DNA fragmentation factor - 45,458,487,Protein	"[{""token"": ""Fas ligand"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Protein""}, {""token"": ""CD95"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Protein""}, {""token"": ""caspase - 1"", ""start_span"": 258, ""end_span"": 269, ""type"": ""Protein""}, {""token"": ""caspase - 3"", ""start_span"": 306, ""end_span"": 317, ""type"": ""Protein""}, {""token"": ""CPP32"", ""start_span"": 327, ""end_span"": 332, ""type"": ""Protein""}, {""token"": ""Yama"", ""start_span"": 335, ""end_span"": 339, ""type"": ""Protein""}, {""token"": ""apopain"", ""start_span"": 342, ""end_span"": 349, ""type"": ""Protein""}, {""token"": ""caspase - 6"", ""start_span"": 356, ""end_span"": 367, ""type"": ""Protein""}, {""token"": ""caspase - 3"", ""start_span"": 399, ""end_span"": 410, ""type"": ""Protein""}, {""token"": ""DNA fragmentation factor - 45"", ""start_span"": 458, ""end_span"": 487, ""type"": ""Protein""}]"	valid
To investigate the molecular mechanism of the inhibitory effect on transcriptional or post - transcriptional regulation of IL - 6 gene expression by IL - 4 and IL - 10, we studied IL - 6 production, expression level of IL - 6 mRNA, IL - 6 promoter activity, transcriptional activity of NF - kappaB and NF - IL - 6, and IL - 6 mRNA stability in human monocytic cell lines, THP - 1 and U937, stimulated by PMA and LPS in the absence or the presence of IL - 4 or IL - 10.	IL - 6,123,129,Protein	IL - 4,149,155,Protein	IL - 10,160,167,Protein	IL - 6,180,186,Protein	IL - 6,219,225,Protein	IL - 6,232,238,Protein	NF - IL - 6,302,313,Protein	IL - 6,319,325,Protein	IL - 4,450,456,Protein	IL - 10,460,467,Protein	"[{""token"": ""IL - 6"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 219, ""end_span"": 225, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 232, ""end_span"": 238, ""type"": ""Protein""}, {""token"": ""NF - IL - 6"", ""start_span"": 302, ""end_span"": 313, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 319, ""end_span"": 325, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 450, ""end_span"": 456, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 460, ""end_span"": 467, ""type"": ""Protein""}]"	test
